ST. LOUIS--(BUSINESS WIRE)--M6P Therapeutics (“M6PT” or “the Company”), a privately held life sciences company developing next-generation recombinant enzyme and gene therapies for lysosomal storage ...
Shire announced that the FDA has granted Fast Track designation to SHP655 (historically BAX930) for the treatment of acute episodes of hereditary thrombotic thrombocytopenic purpura (hTTP) in patients ...
Cell-surface and secreted glycoproteins and glycolipids contribute to numerous interactions with the extracellular environment that influence cellular physiology and pathology 1,2. These interactions ...
Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a 96% majority ownership stake in ...
Dyadic International (DYAI) announced the achievement of additional milestone payments in its collaborations with Proliant Health & Biologicals in ...
JCR announced an exclusive licensing agreement with Menagen to commercialize Agalsidase Beta BS I.V. Infusion [JCR] across ...
The global phospholipase enzyme market is poised for steady expansion, climbing from USD 267.4 million in 2024 to USD 488.4 ...
Global biotechnology company Dyadic Applied BioSolutions has announced the achievement of additional milestone payments in ...
Stay up to date on the latest science with Brush Up Summaries. “Molecular farming started out with transgenic plants,” said Rybicki. Scientists developed several strategies to produce transgenic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback